aldosterone has been researched along with Polycystic Ovarian Syndrome in 18 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " Total renin, aldosterone, androgen levels and insulin sensitivity indices were significantly improved after 6 months on metformin treatment." | 9.14 | Hyperreninemia characterizing women with polycystic ovary syndrome improves after metformin therapy. ( Diamanti-Kandarakis, E; Economou, FN; Livadas, S; Panidis, D; Papavassiliou, AG; Piperi, C; Tantalaki, E, 2009) |
| "The aim of the study was to compare the effect of spironolactone (antagonist of mineralocorticoid and androgen receptors) versus spironolactone plus licorice (agonist of mineralocorticoid receptors and mild inhibitor of androgen synthesis) on plasma renin activity, aldosterone and androgen levels in women with polycystic ovary syndrome (PCOS)." | 9.12 | Treatment of polycystic ovary syndrome with spironolactone plus licorice. ( Armanini, D; Bertoldo, A; Bonanni, G; Castello, R; Faccini, G; Fiore, C; Moghetti, P; Pellati, D; Scaroni, C, 2007) |
| "Treatment with spironolactone normalized endothelial function and improved cholesterol levels in non-obese PCOS patients." | 6.76 | Influence of spironolactone treatment on endothelial function in non-obese women with polycystic ovary syndrome. ( Pfeifer, M; Prezelj, J; Sebestjen, M; Studen, KB, 2011) |
| "Aldosterone is a well-recognized cardiovascular risk (CVR) factor and is related to inflammatory processes." | 5.33 | Serum aldosterone concentration and cardiovascular risk in women with polycystic ovarian syndrome. ( Cascella, T; Colao, A; Di Biase, S; Giallauria, F; Labella, D; Lombardi, G; Manguso, F; Orio, F; Palomba, S; Tauchmanovà, L; Vigorito, C, 2006) |
| " Total renin, aldosterone, androgen levels and insulin sensitivity indices were significantly improved after 6 months on metformin treatment." | 5.14 | Hyperreninemia characterizing women with polycystic ovary syndrome improves after metformin therapy. ( Diamanti-Kandarakis, E; Economou, FN; Livadas, S; Panidis, D; Papavassiliou, AG; Piperi, C; Tantalaki, E, 2009) |
| "The aim of this study was to assess novel inflammatory markers [adipokines leptin, adiponectin, and leptinadiponectin ratio (L/A)] in overweight women with and without PCOS and to examine alterations in these markers [aldosterone, leptin, adiponectin, and L/A] with pharmacological interventions modulating insulin resistance (IR) in PCOS." | 5.14 | Novel inflammatory markers in overweight women with and without polycystic ovary syndrome and following pharmacological intervention. ( Hutchison, SK; Meyer, C; Moran, LJ; Teede, HJ; Zoungas, S, 2010) |
| "The aim of the study was to compare the effect of spironolactone (antagonist of mineralocorticoid and androgen receptors) versus spironolactone plus licorice (agonist of mineralocorticoid receptors and mild inhibitor of androgen synthesis) on plasma renin activity, aldosterone and androgen levels in women with polycystic ovary syndrome (PCOS)." | 5.12 | Treatment of polycystic ovary syndrome with spironolactone plus licorice. ( Armanini, D; Bertoldo, A; Bonanni, G; Castello, R; Faccini, G; Fiore, C; Moghetti, P; Pellati, D; Scaroni, C, 2007) |
| "Ovarian hyperstimulation syndrome occurred after induction of ovulation with menotropins (follicle-stimulating hormone and luteinizing hormone) and implantation of an intrauterine pregnancy." | 3.67 | Pathophysiology of the ovarian hyperstimulation syndrome. ( Haning, RV; Nolten, WE; Strawn, EY, 1985) |
| "Treatment with spironolactone normalized endothelial function and improved cholesterol levels in non-obese PCOS patients." | 2.76 | Influence of spironolactone treatment on endothelial function in non-obese women with polycystic ovary syndrome. ( Pfeifer, M; Prezelj, J; Sebestjen, M; Studen, KB, 2011) |
| "(1) Within a normotensive range, hyperinsulinemia and/or insulin resistance influence daily BP variation more than obesity does, suggesting a pivotal role of insulin on BP control in PCOS; (2) altered insulinemic state and ABPM-derived higher nighttime BP and HR may represent early markers to identify PCOS subjects prone to high cardiovascular risk." | 1.46 | Hyperinsulinemia and obese phenotype differently influence blood pressure in young normotensive patients with polycystic ovary syndrome. ( Azzolini, S; Bleve, L; Cà, AD; Fallo, F; Maffei, P; Mioni, R; Turra, J; Vettor, R; Xamin, N, 2017) |
| "Aldosterone is a well-recognized cardiovascular risk (CVR) factor and is related to inflammatory processes." | 1.33 | Serum aldosterone concentration and cardiovascular risk in women with polycystic ovarian syndrome. ( Cascella, T; Colao, A; Di Biase, S; Giallauria, F; Labella, D; Lombardi, G; Manguso, F; Orio, F; Palomba, S; Tauchmanovà, L; Vigorito, C, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (11.11) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (38.89) | 29.6817 |
| 2010's | 7 (38.89) | 24.3611 |
| 2020's | 2 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Amin, M | 1 |
| Perrelli, M | 1 |
| Wu, R | 1 |
| Gragnoli, C | 1 |
| Kfoury, B | 1 |
| Cohen, JB | 1 |
| Muneyyirci-Delale, O | 1 |
| Kaplan, J | 1 |
| Joulak, I | 1 |
| Yang, L | 1 |
| Von Gizycki, H | 1 |
| Nacharaju, VL | 1 |
| Armanini, D | 4 |
| Sabbadin, C | 2 |
| Donà, G | 2 |
| Andrisani, A | 1 |
| Ambrosini, G | 1 |
| Bordin, L | 2 |
| Mioni, R | 1 |
| Cà, AD | 1 |
| Turra, J | 1 |
| Azzolini, S | 1 |
| Xamin, N | 1 |
| Bleve, L | 1 |
| Maffei, P | 1 |
| Vettor, R | 1 |
| Fallo, F | 1 |
| Diamanti-Kandarakis, E | 1 |
| Economou, FN | 1 |
| Livadas, S | 1 |
| Tantalaki, E | 1 |
| Piperi, C | 1 |
| Papavassiliou, AG | 1 |
| Panidis, D | 1 |
| Moran, LJ | 1 |
| Meyer, C | 1 |
| Hutchison, SK | 1 |
| Zoungas, S | 1 |
| Teede, HJ | 1 |
| Studen, KB | 1 |
| Sebestjen, M | 1 |
| Pfeifer, M | 1 |
| Prezelj, J | 1 |
| Mejia-Montilla, J | 1 |
| Reyna-Villasmil, E | 1 |
| Torres-Cepeda, D | 1 |
| Santos-Bolívar, J | 1 |
| Reyna-Villasmil, N | 1 |
| Bravo-Henríquez, A | 1 |
| Bakdounes, L | 1 |
| Ragazzi, E | 1 |
| Giorgino, FL | 1 |
| Fiore, C | 3 |
| Uncu, G | 1 |
| Sözer, MC | 1 |
| Develioğlu, O | 1 |
| Cengiz, C | 1 |
| Zhao, SP | 1 |
| Tang, XM | 1 |
| Shao, DH | 1 |
| Dai, HY | 1 |
| Dai, SZ | 1 |
| Cascella, T | 1 |
| Palomba, S | 1 |
| Tauchmanovà, L | 1 |
| Manguso, F | 1 |
| Di Biase, S | 1 |
| Labella, D | 1 |
| Giallauria, F | 1 |
| Vigorito, C | 1 |
| Colao, A | 1 |
| Lombardi, G | 1 |
| Orio, F | 1 |
| Castello, R | 1 |
| Scaroni, C | 1 |
| Bonanni, G | 1 |
| Faccini, G | 1 |
| Pellati, D | 2 |
| Bertoldo, A | 1 |
| Moghetti, P | 1 |
| King, AJ | 1 |
| Olivier, NB | 1 |
| Mohankumar, PS | 1 |
| Lee, JS | 1 |
| Padmanabhan, V | 1 |
| Fink, GD | 1 |
| Haning, RV | 1 |
| Strawn, EY | 1 |
| Nolten, WE | 1 |
| Graef, V | 1 |
1 review available for aldosterone and Polycystic Ovarian Syndrome
| Article | Year |
|---|---|
[Enzyme defects in steroid hormone biosynthesis].
Topics: Adrenal Cortex Hormones; Adrenal Glands; Adrenal Hyperplasia, Congenital; Aldosterone; Estrogens; Fe | 1973 |
6 trials available for aldosterone and Polycystic Ovarian Syndrome
| Article | Year |
|---|---|
Serum free fatty acid levels in PCOS patients treated with glucophage, magnesium oxide and spironolactone.
Topics: Adolescent; Adult; Aldosterone; Drug Therapy, Combination; Fatty Acids, Nonesterified; Female; Human | 2013 |
Hyperreninemia characterizing women with polycystic ovary syndrome improves after metformin therapy.
Topics: Adult; Aldosterone; Androgens; Area Under Curve; Blood Glucose; Case-Control Studies; Female; Humans | 2009 |
Novel inflammatory markers in overweight women with and without polycystic ovary syndrome and following pharmacological intervention.
Topics: Adiponectin; Adiposity; Aldosterone; Biomarkers; Body Mass Index; Cross-Sectional Studies; Female; H | 2010 |
Influence of spironolactone treatment on endothelial function in non-obese women with polycystic ovary syndrome.
Topics: Adult; Aldosterone; Androgen Antagonists; Androgens; Androstenedione; Dehydroepiandrosterone Sulfate | 2011 |
[Plasma renin and aldosterone levels in obese and non-obese women with polycystic ovary syndrome].
Topics: Adult; Aldosterone; Blood Glucose; Body Mass Index; Female; Follicle Stimulating Hormone; Gonadal St | 2012 |
Treatment of polycystic ovary syndrome with spironolactone plus licorice.
Topics: Adult; Aldosterone; Androgens; Blood Pressure; Diuretics; Drug Therapy, Combination; Female; Glycyrr | 2007 |
11 other studies available for aldosterone and Polycystic Ovarian Syndrome
| Article | Year |
|---|---|
The mineralocorticoid receptor gene (NR3C2) is linked to and associated with polycystic ovarian syndrome in Italian families.
Topics: Aldosterone; Diabetes Mellitus, Type 2; Female; Humans; Hyperandrogenism; Insulin Resistance; Minera | 2023 |
Elevated Renin and Aldosterone Levels in a Young Woman With Hypertension.
Topics: Adult; Aldosterone; Androstenes; Antihypertensive Agents; Computed Tomography Angiography; Contracep | 2020 |
Maternal and Fetal Outcomes in Preeclampsia: Interrelations Between Insulin Resistance, Aldosterone, Metabolic Syndrome, and Polycystic Ovary Syndrome.
Topics: Aldosterone; Female; Humans; Hypertension; Insulin; Insulin Resistance; Metabolic Syndrome; Polycyst | 2015 |
Hyperinsulinemia and obese phenotype differently influence blood pressure in young normotensive patients with polycystic ovary syndrome.
Topics: Adolescent; Adult; Aldosterone; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Cross-Section | 2017 |
Polycystic ovary syndrome: Implications of measurement of plasma aldosterone, renin activity and progesterone.
Topics: Adult; Aldosterone; Case-Control Studies; Female; Humans; Luteal Phase; Polycystic Ovary Syndrome; P | 2012 |
The role of plasma renin activity in distinguishing patients with polycystic ovary syndrome (PCOS) from oligomenorrheic patients without PCOS.
Topics: 17-alpha-Hydroxyprogesterone; Adult; Aldosterone; Dehydroepiandrosterone Sulfate; Diagnosis, Differe | 2002 |
[Association study between a polymorphism of aldosterone synthetase gene and the pathogenesis of polycystic ovary syndrome].
Topics: Adult; Aldosterone; Cytochrome P-450 CYP11B2; Female; Gene Frequency; Genotype; Humans; Polycystic O | 2003 |
Serum aldosterone concentration and cardiovascular risk in women with polycystic ovarian syndrome.
Topics: Adult; Aldosterone; Atherosclerosis; Cardiovascular Diseases; Case-Control Studies; Causality; Femal | 2006 |
Hypertension caused by prenatal testosterone excess in female sheep.
Topics: Aldosterone; Animals; Blood Pressure; Chlorides; Cholesterol; Disease Models, Animal; Dyslipidemias; | 2007 |
Polycystic ovary syndrome: implications of corticotropin in the regulation of blood pressure, aldosterone, and androgen secretion.
Topics: Adrenocorticotropic Hormone; Aldosterone; Biomarkers; Blood Pressure; Female; Humans; Hypertension; | 2007 |
Pathophysiology of the ovarian hyperstimulation syndrome.
Topics: Adult; Aldosterone; Anovulation; Chorionic Gonadotropin; Desoxycorticosterone; Electrolytes; Female; | 1985 |